BLOG2021-02-12T04:29:57+00:00

Critical Issue Management

Critical Issue Management for FDA 483 Warning Letters, Recalls & Safety Alerts Agency Representation & Negotiation Recalls, Field Corrections & Safety Alerts 483/Warning Letter/Consent Decree Resolution Compliance Certification Import Alert & Detention Removal Programs Consent Decree Programs HIPAA Subpoenas Government Investigations Major Product's Liability Litigation Integrity Inquiries Import Alerts/Bans Seizure Injunctions Administrative Detention Civil Actions Criminal Actions Corporate or Multi-Facility Warning Letters Monitoring of North American & European Union Regulatory Activities What is Critical Issue Management? BioTeknica, an IQVIA business, can help resolve issues arising from FDA management [...]

By |February 2nd, 2021|Tags: , , |
2901, 2021

Regulatory Services

January 29th, 2021|0 Comments

Regulatory Services for Medical Device & Pharmaceutical Industries BioTeknica provides expert clinical and regulatory [...]

Get to the Head of the Class: Lunch & Learn Series at BioTeknica’s New Learning Center

By |October 5th, 2018|Categories: Blog, S3 Compliance Matters|

Get to the Head of the Class: Lunch & Learn Series at BioTeknica's New Learning Center BioTeknica recently launched Lunch & Learn, a [...]

Julie Larsen Joins FDANews Medical Device Conference Advisory Board

By |October 5th, 2018|Categories: Blog, S3 Compliance Matters|

Julie Larsen Joins FDANews Medical Device Conference Advisory Board Congratulations to BioTeknica principal Julie Larsen for her recent invitation and acceptance to join [...]

FDA Program Realignment: New Model for Device Approval & Inspection Efficiency

By |October 4th, 2018|Categories: Blog, S3 Compliance Matters|

FDA Program Realignment: New Model for Device Approval & Inspection Efficiency The FDA Center for Devices and Radiological Health (CDRH) has submitted a reorganization plan [...]

Go to Top